Biomarkers for sepsis: A review with special attention to India

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Nelson, George E ^a   Mave, Vidya ^a,b   Gupta, Amita ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b B J MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; CALCITONIN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PROTEIN PRECURSOR; TREM1 PROTEIN, HUMAN;

ANTIBIOTIC THERAPY; COST CONTROL; ERYTHROCYTE SEDIMENTATION RATE; HEALTH CARE PLANNING; HUMAN; INDIA; LEUKOCYTE; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; BLOOD;

BIOLOGICAL MARKERS; CALCITONIN; HUMANS; INDIA; MEMBRANE GLYCOPROTEINS; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC; SEPSIS;

EID: 84897475983     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/264351     Document Type: Review

References (132)

1. Jawad I., Lukšić I., Rafnsson S. B., Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. Journal of Global Health 2012 2 1 10404 10. 7189/jogh. 02. 010404
2. Lahariya C., Sudfeld C. R., Lahariya D., Tomar S. S., Causes of child deaths in India, 1985-2008: a systematic review of literature. Indian Journal of Pediatrics 2010 77 11 1303 1311 2-s2.0-78651087058 10.1007/s12098-010-0246-3
3. Lahariya C., Paul V. K., Burden, differentials, and causes of child deaths in India. Indian Journal of Pediatrics 2010 77 11 1312 1321 2-s2.0-78651067663 10.1007/s12098-010-0185-z
4. Bone R. C., Balk R. A., Cerra F. B., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. THE ACCP/SCCM consensus conference committee. Chest 1992 101 1644 1655
5. Goldstein B., Giroir B., Randolph A., International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Medicine 2005 6 1 2 98 2-s2.0-21644438082 10.1097/01.PCC.0000149131.72248.E6 (Pubitemid 40956461)
6. Dellinger R. P., Carlet J. M., Masur H., Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Critical Care Medicine 2004 32 858 873 2-s2.0-5644220075 (Pubitemid 38344143)
7. Dellinger R. P., Levy M. M., Carlet J. M., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Critical Care Medicine 2008 36 296 327 2-s2.0-41649088783
8. Khilnani P., Deopujari S., Carcillo J., Recent advances in sepsis and septic shock. Indian Journal of Pediatrics 2008 75 8 821 830 2-s2.0-51349114682 10.1007/s12098-008-0154-y
9. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J.-L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B (Pubitemid 36444440)
10. Flayhart D., Borek A. P., Wakefield T., Dick J., Carroll K. C., Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. Journal of Clinical Microbiology 2007 45 3 816 821 2-s2.0-33947200338 10.1128/JCM.02064-06 (Pubitemid 46427696)
11. Zadroga R., Williams D. N., Gottschall R., Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clinical Infectious Diseases 2013 56 6 790 797 10.1093/cid/cis1021
12. Puskarich M. A., Trzeciak S., Shapiro N. I., Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Critical Care Medicine 2011 39 9 2066 2071 10.1097/CCM.0b013e31821e87ab
13. Shorr A. F., Micek S. T., Welch E. C., Doherty J. A., Reichley R. M., Kollef M. H., Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Critical Care Medicine 2011 39 1 46 51 2-s2.0-78651257740 10.1097/CCM.0b013e3181fa41a7
14. Cheah A. L., Spelman T., Liew D., Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clinical Microbiology and Infection 2013 19 4 E181 E189 10.1111/1469-0691.12132
15. Reinhart K., Bauer M., Riedemann N. C., Hartog C. S., New approaches to sepsis: molecular diagnostics and biomarkers. Journal of Clinical Microbiology 2012 25 4 609 634 10.1128/CMR.00016-12
16. Pierrakos C., Vincent J. L., Sepsis biomarkers: a review. Critical Care 2010 14 1, article R15 10.1186/cc8872
17. Census Provisional Population Totals The Registrar General and Census Commissioner
18. World Health Statistics 2011 World Health Organization
19. Deen J., von Seidlein L., Andersen F., Elle N., White N. J., Lubell Y., Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. The Lancet Infectious Diseases 2012 12 6 480 487 10.1016/S1473-3099(12)70028-2
20. Bhattacharya S., Blood culture in India: a proposal for a national programme for early detection of sepsis. Indian Journal of Medical Microbiology 2005 23 4 220 226 2-s2.0-28844442953 (Pubitemid 41769361)
21. Vincent J.-L., Dear SIRS, I'm sorry to say that I don't like you. Critical Care Medicine 1997 25 2 372 374 2-s2.0-0031035860 10.1097/00003246- 199702000-00029 (Pubitemid 27086078)
22. Bogar L., Molnar Z., Kenyeres P., Tarsoly P., Sedimentation characteristics of leucocytes can predict bacteraemia in critical care patients. Journal of Clinical Pathology 2006 59 5 523 525 2-s2.0-33646418962 10.1136/jcp.2005.033035
23. Davis B. H., Bigelow N. C., Comparison of neutrophil CD64 expression, manual myeloid immaturity counts, and automated hematology analyzer flags as indicators of infection or sepsis. Laboratory Hematology 2005 11 2 137 147 2-s2.0-22144456710 10.1532/LH96.04077 (Pubitemid 40975556)
24. Müller B., Harbarth S., Stolz D D., Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infectious Diseases 7, article 10 10.1186/1471-2334-7-10
25. Dellinger R. P., Levy M. M., Rhodes A., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Critical Care Medicine 2013 41 2 580 637 10.1097/CCM.0b013e31827e83af
26. Borthwick H. A., Brunt L. K., Mitchem K. L., Chaloner C., Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Annals of Clinical Biochemistry 2012 49 4 391 394 10.1258/acb.2011.011227
27. Jones A. E., Shapiro N. I., Trzeciak S., Arnold R. C., Claremont H. A., Kline J. A., Lactate clearance versus central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. Journal of the American Medical Association 2010 303 8 739 746 2-s2.0-77249162677 10.1001/jama.2010.158
28. Barati M., Alinejad F., Bahar M. A., Tabrisi M. S., Shamshiri A. R., Bodouhi N.-O., Karimi H., Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns 2008 34 6 770 774 2-s2.0-47649124819 10.1016/j.burns.2008.01.014
29. Osei-Bimpong A., Meek J. H., Lewis S. M., ESR or CRP? A comparison of their clinical utility. Hematology 2007 12 4 353 357 2-s2.0-34547518237 10.1080/10245330701340734 (Pubitemid 47180665)
30. Shine B., De Beer F. C., Pepys M. B., Solid phase radioimmunoassays for human C-reactive protein. Clinica Chimica Acta 1981 117 1 13 23 2-s2.0-0019840538 10.1016/0009-8981(81)90005-X (Pubitemid 12228482)
31. Gabay C., Kushner I., Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 1999 340 6 448 454 2-s2.0-0033545342 10.1056/NEJM199902113400607 (Pubitemid 29084777)
32. Vigushin D. M., Pepys M. B., Hawkins P. N., Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. Journal of Clinical Investigation 1993 91 4 1351 1357 2-s2.0-0027316064 (Pubitemid 23127332)
33. Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G.-Y., Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Critical Care Medicine 2006 34 7 1996 2003 2-s2.0-33745622134 10.1097/01.CCM.0000226413.54364.36 (Pubitemid 43982479)
34. Ho K. M., Lipman J., An update on C-reactive protein for intensivists. Anaesthesia and Intensive Care 2009 37 2 234 241 2-s2.0-65549144770
35. Limper M., de Kruif M. D., Duits A. J., Brandjes D. P. M., van Gorp E. C. M., The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. Journal of Infection 2010 60 6 409 416 2-s2.0-77953322360 10.1016/j.jinf.2010.03.016
36. Kim K.-E., Han J.-Y., Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection. Korean Journal of Laboratory Medicine 2010 30 2 153 159 2-s2.0-77954851953 10.3343/kjlm.2010.30.2.153
37. Póvoa P., Souza-Dantas V. C., Soares M., Salluh J. I. F., C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Critical Care 2011 15 3, article R129 2-s2.0-79955984559 10.1186/cc10242
38. Engel A., Mack E., Kern P., Kern W. V., An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998 26 4 213 221 2-s2.0-0031868761 (Pubitemid 28388878)
39. Lobo S. M. A., Lobo F. R. M., Peres Bota D., Lopes-Ferreira F., Soliman H. M., Mélot C., Vincent J.-L., C-reactive protein levels correlate with mortality and organ failure in critically III patients. Chest 2003 123 6 2043 2049 2-s2.0-0037709770 10.1378/chest.123.6.2043 (Pubitemid 36706731)
40. Tschaikowsky K., Hedwig-Geissing M., Braun G. G., Radespiel-Troeger M., Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. Journal of Critical Care 2011 26 1 54 64 2-s2.0-79551519906 10.1016/j.jcrc.2010.04.011
41. Tschaikowsky K., Hedwig-Geissing M., Schmidt J., Braun G. G., Lipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant? PLoS ONE 2011 6 8 2-s2.0-80052077015 10.1371/journal.pone.0023615 e23615
42. Sakr Y., Burgett U., Nacul F. E., Reinhart K., Brunkhorst F., Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Critical Care Medicine 2008 36 7 2014 2022 2-s2.0-47249142905 10.1097/CCM.0b013e31817b86e3
43. Abe R., Oda S., Sadahiro T., Nakamura M., Hirayama Y., Tateishi Y., Shinozaki K., Hirasawa H., Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Critical Care 2010 14 2, article R27 2-s2.0-78149250525 10.1186/cc8898
44. Chaudhary N., Kosaraju K., Bhat K., Bairy I., Borker A., Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study. Journal of Pediatric Hematology/Oncology 2012 34 8 617 623 10.1097/MPH. 0b013e3182677fc6
45. Sugitharini V., Prema A., Berla Thangam E., Inflammatory mediators of systemic inflammation in neonatal sepsis. Inflammation Research 2013 62 12 1025 1034 10.1007/s00011-013-0661-9
46. Kumar S., Rizvi M., Serum tumor necrosis factor alpha and C-reactive protein in pediatric patients with sepsis and its correlation with microbiologic findings. Indian Journal of Pathology and Microbiology 2010 53 3 494 497 10.4103/0377-4929.68290
47. Paul R., Sinha P. K., Bhattacharya R., Banerjee A. K., Raychaudhuri P., Mondal J., Study of C reactive protein as a prognostic marker in malaria from Eastern India. Advanced Biomedical Research 2012 1, article 41 10.4103/2277-9175.100140
48. Mahajan A., Tabassum R., Chavali S., Dwivedi O. P., Chauhan G., Ghosh S., Tandon N., Bharadwaj D., Common variants in CRP and LEPR influence high sensitivity C-reactive protein levels in North Indians. PLoS ONE 2011 6 9 2-s2.0-80052551725 10.1371/journal.pone.0024645 e24645
49. Chandalia M., Cabo-Chan A. V. Jr., Devaraj S., Jialal I., Grundy S. M., Abate N., Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. Journal of Clinical Endocrinology and Metabolism 2003 88 8 3773 3776 2-s2.0-0042384395 10.1210/jc.2003-030301 (Pubitemid 37034527)
50. Chesney R. W., McCarron D. M., Haddad J. G., Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. Journal of Laboratory and Clinical Medicine 1983 101 4 576 585 2-s2.0-0020548956 (Pubitemid 13119185)
51. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C., High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet 1993 341 8844 515 518 2-s2.0-0027466275 10.1016/0140-6736(93)90277-N (Pubitemid 23066085)
52. Brunkhorst F. M., Heinz U., Forycki Z. F., Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Medicine 1998 24 8 888 889 2-s2.0-0031707475 10.1007/s001340050683 (Pubitemid 28431680)
53. Dandona P., Nix D., Wilson M. F., Aljada A., Love J., Assicot M., Bohuon C., Procalcitonin increase after endotoxin injection in normal subjects. Journal of Clinical Endocrinology and Metabolism 1994 79 6 1605 1608 2-s2.0-0028575739
54. Snider R. H. Jr., Nylen E. S., Becker K. L., Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. Journal of Investigative Medicine 1997 45 9 552 560 2-s2.0-0031302675 (Pubitemid 127806489)
55. Müller B., White J. C., Nylén E. S., Snider R. H., Becker K. L., Ubiquitous expression of the calcitonin I gene in multiple tissues in response to sepsis. Journal of Clinical Endocrinology and Metabolism 2001 86 1 396 404 (Pubitemid 32109825)
56. Linscheid P., Seboek D., Nylen E. S., Langer I., Schlatter M., Becker K. L., Keller U., Müller B., In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003 144 12 5578 5584 2-s2.0-0344825792 10.1210/en.2003-0854 (Pubitemid 37476087)
57. Brunkhorst F. M., Eberhard O. K., Brunkhorst R., Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Critical Care Medicine 1999 27 10 2172 2176 2-s2.0-0032734656 10.1097/00003246-199910000-00016 (Pubitemid 29508332)
58. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G. E., Vadas L., Pugin J., Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. The American Journal of Respiratory and Critical Care Medicine 2001 164 3 396 402 2-s2.0-0035421655 (Pubitemid 32778205)
59. Müller B., Becker K. L., Schächinger H., Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical Care Medicine 2000 28 4 977 983 (Pubitemid 30262065)
60. Chalupa P., Beran O., Herwald H., Kaspříková N., Holub M., Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011 39 5 411 417 2-s2.0-80755139728 10.1007/s15010-011-0126-4
61. Ahn S., Kim W. Y., Kim S.-H., Hong S., Lim C.-M., Koh Y., Lim K. S., Kim W., Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. Influenza and other Respiratory Viruses 2011 5 6 398 403 2-s2.0-80054782329 10.1111/j.1750-2659. 2011.00244.x
62. Cuquemelle E., Soulis F., Villers D., Roche-Campo F., Ara Somohano C., Fartoukh M., Kouatchet A., Mourvillier B., Dellamonica J., Picard W., Schmidt M., Boulain T., Brun-Buisson C., Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Medicine 2011 37 5 796 800 2-s2.0-79955554735 10.1007/s00134-011-2189-1
63. van Nieuwkoop C., Bonten T. N., van't Wout J. W., Kuijper E. J., Groeneveld G. H., Becker M. J., Koster T., Wattel-Louis G. H., Delfos N. M., Ablij H. C., Leyten E. M. S., van Dissel J. T., Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Critical Care 2010 14 6, article R206 2-s2.0-78349243323 10.1186/cc9328
64. Müller F., Christ-Crain M., Bregenzer T., Krause M., Zimmerli W., Mueller B., Schuetz P., Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 2010 138 1 121 129 2-s2.0-77952273695 10.1378/chest.09-2920
65. Riedel S., Melendez J. H., An A. T., Rosenbaum J. E., Zenilman J. M., Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. The American Journal of Clinical Pathology 2011 135 2 182 189 2-s2.0-79952271594 10.1309/AJCP1MFYINQLECV2
66. Tang B. M., Eslick G. D., Craig J. C., McLean A. S., Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. The Lancet Infectious Diseases 2007 7 3 210 217 2-s2.0-33847056146 10.1016/S1473-3099(07)70052-X (Pubitemid 46274517)
67. Simon L., Gauvin F., Amre D. K., Saint-Louis P., Lacroix J., Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical Infectious Diseases 2004 39 2 206 217 2-s2.0-3242810355 10.1086/421997 (Pubitemid 38971491)
68. Wacker C., Prkno A., Brunkhorst F. M., Schlattmann P., Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. The Lancet Infectious Diseases 2013 13 5 426 435 10.1016/S1473-3099(12)70323-7
69. Jones A. E., Fiechtl J. F., Brown M. D., Ballew J. J., Kline J. A., Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Annals of Emergency Medicine 2007 50 1 34 41 2-s2.0-33847204123 10.1016/j.annemergmed. 2006.10.020 (Pubitemid 46907302)
70. Tsalik E. L., Jaggers L. B., Glickman S. W., Discriminative value of inflammatory biomarkers for suspected sepsis. Journal of Emergency Medicine 2012 43 1 97 106
71. Clec'h C., Fosse J.-P., Karoubi P., Vincent F., Chouahi I., Hamza L., Cupa M., Cohen Y., Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Critical Care Medicine 2006 34 1 102 107 2-s2.0-29744443754 10.1097/01.CCM.0000195012.54682.F3 (Pubitemid 43032386)
72. Rossum A. M. C. V., Wulkan R. W., Oudesluys-Murphy A. M., Procalcitonin as an early marker of infection in neonates and children. The Lancet Infectious Diseases 2004 4 10 620 630 2-s2.0-4644371441 10.1016/S1473-3099(04)01146-6 (Pubitemid 39296836)
73. Sakr Y., Sponholz C., Tuche F., Brunkhorst F., Reinhart K., The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008 36 5 396 407 2-s2.0-56549122800 10.1007/s15010-008-7374-y
74. Müller B., Peri G., Doni A., Perruchoud A. P., Landmann R., Pasqualini F., Mantovani A., High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. Journal of Leukocyte Biology 2002 72 4 643 649 2-s2.0-0036826851 (Pubitemid 36277834)
75. Charles P. E., Dalle F., Aho S., Quenot J.-P., Doise J.-M., Aube H., Olsson N.-O., Blettery B., Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Medicine 2006 32 10 1577 1583 2-s2.0-33749242466 10.1007/s00134-006-0306-3 (Pubitemid 44484348)
76. Dou Y. H., Du J. K., Liu H. L., Shong X. D., The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagnostic Microbiology and Infectious Disease 2013 76 4 464 469 10.1016/j.diagmicrobio.2013.04.023
77. Peter J. V., Karthik K G., Elevated procalcitonin is associated with increased mortality in patients with scrub typhus infection needing intensive care admission. Indian Journal of Critical Care Medicine 2013 17 3 174 177 10.4103/0972-5229.117063
78. Maharajan K., Patro D. K., Menon J., Serum Procalcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitis. Journal of Orthopaedic Surgery and Research 2013 8, article 19 10.1186/1749-799X-8-19
79. Kumar T. C., Shivakumar N. S., Deepak T. S., Krishnappa R., Goutam M. S., Ganigar V., H1N1-infected patients in ICU and their clinical outcome. North American Journal of Medical Sciences 2012 4 9 394 398 10.4103/1947-2714.100984
80. Shafiq N., Malhotra S., Bhasin D. K., Rana S., Siddhu S., Pandhi P., Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta-analytic approach. Journal of the Pancreas 2005 6 3 231 237 2-s2.0-27644500163 (Pubitemid 41573805)
81. Khanna A. K., Meher S., Prakash S., Comparison of ranson, glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis. HPB Surgery 2013 2013 10 367581 10.1155/2013/367581
82. Singh J., Kekre N., Procalcitonin: a marker of renal parenchymal infection in children? Indian Journal of Urology 2006 22 2 162 163 2-s2.0-33746419248 (Pubitemid 44125572)
83. Prasad R., Kapoor R., Mishra O. P., Srivastava R., Kant Singh U., Serum procalcitonin in septic meningitis. Indian Journal of Pediatrics 2013 80 5 365 370 10.1007/s12098-012-0933-3
84. Rowther F. B., Rodrigues C. S., Deshmukh M. S., Kapadia F. N., Hegde A., Mehta A. P., Joshi V. R., Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients. Journal of Clinical Microbiology 2009 47 9 2964 2969 2-s2.0-69949100886 10.1128/JCM.00418-07
85. Sudhir U., Venkatachalaiah R. K., Kumar T. A., Rao M. Y., Kempegowda P., Significance of serum procalcitonin in sepsis. Indian Journal of Critical Care Medicine 2011 15 1 1 5 2-s2.0-79953833970 10.4103/0972-5229.78214
86. Sinha M., Desai S., Mantri S., Kulkarni A., Procalcitonin as an adjunctive biomarker in sepsis. Indian Journal of Anaesthesia 2011 55 3 266 270 10.4103/0019-5049.82676
87. Ganguly N. K., Arora N. K., Chandy S. J., Rationalizing antibiotic use to limit antibiotic resistance in India. Indian Journal of Medical Research 2011 134 281 294
88. Ghafur A., Mathai D., Muruganathan A., The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian Journal of Cancer 2013 50 1 71 73 10.4103/0019-509X.104065
89. Nobre V., Harbarth S., Graf J.-D., Rohner P., Pugin J., Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. The American Journal of Respiratory and Critical Care Medicine 2008 177 5 498 505 2-s2.0-40649087642 10.1164/rccm.200708-1238OC (Pubitemid 351442188)
90. Hochreiter M., Köhler T., Schweiger A. M., Keck F. S., Bein B., von Spiegel T., Schroeder S., Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Critical Care 2009 13 3, article R83 2-s2.0-67650917117 10.1186/cc7903
91. Bouadma L., Luyt C.-E., Tubach F., Cracco C., Alvarez A., Schwebel C., Schortgen F., Lasocki S., Veber B., Dehoux M., Bernard M., Pasquet B., Régnier B., Brun-Buisson C., Chastre J., Wolff M., Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. The Lancet 2010 375 9713 463 474 2-s2.0-75949113583 10.1016/S0140-6736(09)61879-1
92. Schuetz P., Mueller B., Trampuz A., Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007 35 5 352 355 2-s2.0-34848848687 10.1007/s15010-007-7065-0 (Pubitemid 47502359)
93. Schuetz P., Müller B., Christ-Crain M., Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews 2012 12, article 9 007498 10.1002/14651858. CD007498.pub2
94. Agarwal R., Schwartz D. N., Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clinical Infectious Diseases 2011 53 4 379 387 2-s2.0-79961239058 10.1093/cid/cir408
95. Schuetz P., Chiappa V., Briel M., Greenwald J. L., Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Archives of Internal Medicine 2011 171 15 1322 1331 2-s2.0-80051637867 10.1001/ archinternmed.2011.318
96. Tang H., Huang T., Jing J., Shen H., Cui W., Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009 37 6 497 507 2-s2.0-77249139646 10.1007/s15010-009-9034-2
97. Briel M., Schuetz P., Mueller B., Young J., Schild U., Nusbaumer C., Périat P., Bucher H. C., Christ-Crain M., Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Archives of Internal Medicine 2008 168 18 2000 2007 2-s2.0-54049112259 10.1001/archinte.168.18.2000
98. Burkhardt O., Ewig S., Haagen U., Giersdorf S., Hartmann O., Wegscheider K., Hummers-Pradier E., Welte T., Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. European Respiratory Journal 2010 36 3 601 607 2-s2.0-77956563149 10.1183/09031936.00163309
99. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M. M., Huber P. R., Tamm M., Müller B., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. The Lancet 2004 363 9409 600 607 2-s2.0-1342265610 10.1016/S0140-6736(04)15591-8 (Pubitemid 38264177)
100. Christ-Crain M., Stolz D., Bingisser R., Müller C., Miedinger D., Huber P. R., Zimmerli W., Harbarth S., Tamm M., Müller B., Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. The American Journal of Respiratory and Critical Care Medicine 2006 174 1 84 93 2-s2.0-33745471090 10.1164/rccm.200512-1922OC (Pubitemid 43955248)
101. Kristoffersen K. B., Søgaard O. S., Wejse C., Black F. T., Greve T., Tarp B., Storgaard M., Sodemann M., Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission: a randomized trial. Clinical Microbiology and Infection 2009 15 5 481 487 2-s2.0-65949114287 10.1111/j.1469-0691.2009.02709.x
102. Schroeder S., Hochreiter M., Koehler T., Schweiger A.-M., Bein B., Keck F. S., Von Spiegel T., Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbeck's Archives of Surgery 2009 394 2 221 226 2-s2.0-59449093757 10.1007/s00423-008-0432-1
103. Heyland D. K., Johnson A. P., Reynolds S. C., Muscedere J., Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Critical Care Medicine 2011 39 7 1792 1799 10.1097/CCM.0b013e31821201a5
104. Kopterides P., Siempos I. I., Tsangaris I., Tsantes A., Armaganidis A., Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Critical Care Medicine 2010 38 11 2229 2241 2-s2.0-78049418360 10.1097/CCM.0b013e3181f17bf9
105. Matthaiou D. K., Ntani G., Kontogiorgi M., Poulakou G., Armaganidis A., Dimopoulos G., An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Medicine 2012 38 940 949 2-s2.0-84860109664 10.1007/s00134-012-2563-7
106. Prkno A., Wacker C., Brunkhorst F. M., Schlattmann P., Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock: a systematic review and meta-analysis. Critical Care 2013 17 6, article R291
107. Kaur K., Mahajan R., Tanwar A., A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting. International Journal of Applied and Basic Medical Research 2013 3 2 77 83 10.4103/2229-516X.117051
108. Thermo Scientific. Welcome to PCT. http://www.procalcitonin.com/
109. Meisner M., Pathobiochemistry and clinical use of procalcitonin. Clinica Chimica Acta 2002 323 1-2 17 29 2-s2.0-0036065119 10.1016/S0009-8981(02)00101-8 (Pubitemid 34804792)
110. Christ-Crain M., Müller B., Procalcitonin in bacterial infections: hype, hope, more or less? Swiss Medical Weekly 2005 135 31-32 451 460 2-s2.0-25444454875 (Pubitemid 41376648)
111. Manzano S., Bailey B., Girodias J.-B., Cousineau J., Delvin E., Gervaix A., Comparison of procalcitonin measurement by a semi-quantitative method and an ultra-sensitive quantitative method in a pediatric emergency department. Clinical Biochemistry 2009 42 15 1557 1560 2-s2.0-70249124886 10.1016/j.clinbiochem.2009.07.005
112. Schuetz P., Christ-Crain M., Huber A. R., Müller B., Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clinical Biochemistry 2010 43 3 341 344 2-s2.0-74249119968 10.1016/j.clinbiochem.2009.08.029
113. Steinbach G., Rau B., Debard A.-L., Javourez J.-F., Bienvenu J., Ponzio A., Bonfà A., Hubl W., Demant T., Külpmann W.-R., Buchholz J., Schumann G., Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clinical Chemistry and Laboratory Medicine 2004 42 4 440 449 2-s2.0-2342644880 10.1515/CCLM.2004.077 (Pubitemid 38585189)
114. Hubl W., Kraßler J., Zingler C., Pertschy A., Hentschel J., Gerhards-Reich C., Mack M., Demant T., Evaluation of a fully automated procalcitonin chemiluminescence immunoassay. Clinical Laboratory 2003 49 7-8 319 327 2-s2.0-0042030995 (Pubitemid 36975251)
115. Bouchon A., Dietrich J., Colonna M., Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. Journal of Immunology 2000 164 10 4991 4995 2-s2.0-0034657890 (Pubitemid 30305166)
116. Cohen J., TREM-1 in sepsis. The Lancet 2001 358 9284 776 778 2-s2.0-0035828402 10.1016/S0140-6736(01)06007-X (Pubitemid 32868722)
117. Bouchon A., Facchetti F., Weigand M. A., Colonna M., TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001 410 6832 1103 1107 2-s2.0-0035953547 10.1038/35074114 (Pubitemid 32391042)
118. Gibot S., Kolopp-Sarda M. N., Bene M. C., Cravoisy A., Levy B., Faure G. C., Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Annals of Internal Medicine 2004 141 9 15 2-s2.0-16844371095
119. Latour-Pérez J., Alcalá-López A., García-García M. A., Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clinical Biochemistry 2010 43 9 720 724
120. Jiyong J., Tiancha H., Wei C., Huahao S., Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Medicine 2009 35 4 587 595 2-s2.0-62949193447 10.1007/s00134-008-1333-z
121. Hamano K., Gohra H., Noda H., Katoh T., Fujimura Y., Zempo N., Esato K., Increased serum interleukin-8: correlation with poor prognosis in patients with postoperative multiple organ failure. World Journal of Surgery 1998 22 10 1077 1081 2-s2.0-0031753175 10.1007/s002689900520 (Pubitemid 28428053)
122. Berner R., Niemeyer C. M., Leititis J. U., Funke A., Schwab C., Rau U., Richter K., Tawfeek M. S. K., Clad A., Brandis M., Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor- α interleukin (IL)-1 β IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatric Research 1998 44 4 469 477 2-s2.0-0031697190 (Pubitemid 28447330)
123. Calfee C. S., Thompson B. T., Parsons P. E., Ware L. B., Matthay M. A., Wong H. R., Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Critical Care Medicine 2010 38 6 1436 1441 2-s2.0-77953081638 10.1097/CCM.0b013e3181de42ad
124. Wong H. R., Cvijanovich N. Z., Hall M., Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Critical Care 2012 16 5, article R213
125. Xing K., Murthy S., Liles W. C., Singh J. M., Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Critical Care 2012 16 1, article R7 2-s2.0-84855816724 10.1186/cc11145
126. de Kruif M. D., Limper M., Gerritsen H., Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Critical Care Medicine 2010 38 2 457 463 10.1097/CCM. 0b013e3181b9ec33
127. Andaluz-Ojeda D., Bobillo F., Iglesias V., Almansa R., Rico L., Gandía F., Resino S., Tamayo E., de Lejarazu R. O., Bermejo-Martin J. F., A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 2012 57 3 332 336 2-s2.0-84856381402 10.1016/j.cyto.2011.12.002
128. Kofoed K., Andersen O., Kronborg G., Tvede M., Petersen J., Eugen-Olsen J., Larsen K., Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Critical Care 2007 11, article 38 2-s2.0-34247328556 10.1186/cc5723 (Pubitemid 46629292)
129. Gibot S., Béné N. C., Noel R., Combination biomarkers to
130. Wong H. R., Salisbury S., Xiao Q., The pediatric sepsis biomarker risk model. Critical Care 2012 16, article R174 10.1186/cc11652
131. Mondal S. K., Nag D. R., Bandyopadhyay R., Chakraborty D., Sinha S. K., Neonatal sepsis: role of a battery of immunohematological tests in early diagnosis. International Journal of Applied and Basic Medical Research 2012 2 1 43 47
132. Kibe S., Adams K., Barlow G., Diagnostic and prognostic biomarkers of sepsis in critical care. Journal of Antimicrobial Chemotherapy 2011 66 supplement 2 33 40 10.1093/jac/dkq523